Thursday's Top 10 Articles, Videos on TheStreet
NEW YORK (TheStreet) -- In case you missed them, here are the top 10 most popular articles and videos on TheStreet today. Sign up for free email delivery of our daily Top 10.
Biotech Stock Mailbag: Ampio, Cel-Sci and Ziopharm
Adam Feuerstein
Biotech columnist Adam Feuerstein answers readers' questions about health-care companies.
2 Bank Stocks to Sell and 1 to Buy From Citigroup
Philip van Doorn
Citi analyst Josh Levin on Thursday initiated or assumed coverage for 10 regional banks, with one "Buy" recommendation and two "Sell" calls.
5 Stocks Endowment Funds Are Buying in 2012
Jonas Elmerraji
If you want to follow the moves of a prescient group of professional investors, keep an eye on the endowments. (Stocks include XOM, VWO)
Jonathan Blum
The Terrafugia Transition's price tag is almost $280,000, but that's not stopping interested buyers. 3 Stocks I Saw on TV, April 5
Dan Fitzpatrick
Dan Fitzpatrick examines three stocks viewed on Fast Money. Today's stocks include SBA Communications, Intel, and Microsoft. Why Apple TV Could be Bigger Than You Think
Chris Ciaccia
Analysts believe an Apple-branded television set could be bigger than initially thought. Stocks Stuck Below the Flat Line
Andrea Tse
U.S. stocks slump in early trades, taking their cue from continued weakness in Europe's markets amid worries about rising yields on Spanish debt. The Next Big Thing in Biotech: Vivus
Gregg Greenberg
Senior columnist Adam Feuerstein explains why Vivus is the next big thing in biotech. 3 Things That Could Move Financial Stocks Today
Christopher Westfall
JPMorgan CEO Jamie Dimon earned $23.1 million in 2011 while Morgan Stanley has put some of its mortgage woes in its past. 6 Companies Battling for Americans' Grocery Money
Frank Byrt
Dollar stores and drug stores are the winners, while supermarkets are the losers.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
